Manulife Financial Corporation one of the dominant life insurers. Manulife reports earnings through six divisions and has five major operating divisions - Asia, Canada, U.S. Insurance and U.S. Wealth Management and Corporate. The Global Wealth and Asset Management offers a broad range of personal and family-oriented wealth management products and services focused on individuals and business markets. The segment has three core business lines - John Hancock Wealth Asset Management, John Hancock Variable Annuities and John Hancock Fixed Products. Corporate and Other is comprised of the earnings on assets backing capital. The Canadian division offers a diverse portfolio of products, services and distribution channels. The segment also markets life, health and specialty products, such as travel insurance, to consumers through a number of alternative distribution channels. Through Manulife Bank, the segment offers a variety of lending products including fixed and variable rate mortgages....
+See More2023-07-14 10:32:00 Friday ET
Ray Fair applies his macroeconometric model to study the central features of the U.S. macroeconomy such as price stability and full employment in the dual m
2019-02-09 08:33:00 Saturday ET
Apple provides positive forward guidance on both revenue and profit forecasts for iPhones, iPads, and MacBooks. In the Christmas 2018 festive season, MacBoo
2018-01-25 08:32:00 Thursday ET
After its flagship iPhone X launch, Apple reports its highest quarterly sales revenue over $80 billion in the tech titan's 41-year history. Apple expect
2019-04-03 11:35:00 Wednesday ET
A Florida fintech group Fidelity Information Services initiates the largest $43 billion acquisition of the e-commerce payments processor Worldpay. Fidelity
2020-02-12 09:31:00 Wednesday ET
Mark Zuckerberg develops Facebook as a social network platform to help empower global connections among family and friends. David Kirkpatrick (2011) T
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be